Icecure Medical is trading at $2.80 (+7.69%) as positive cancer-vaccine trial news lifted healthcare-sector sentiment.
- The move appears primarily sector-driven; no fresh company-specific announcement was identified for August 19, 2026.
- Latest reported results, released August 12, showed 45% year-over-year revenue growth.
- Volume was elevated at approximately 156,390 shares versus an average daily volume of 83,250 shares.